enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Coccinia - Wikipedia

   en.wikipedia.org/wiki/Coccinia

   Coccinia grandis is also well known in ayurvedic medicine for diabetes treatment, and modern research seems to confirm that it might be of value in that application. [ citation needed ] Primary literature

3. Coccinia grandis - Wikipedia

   en.wikipedia.org/wiki/Coccinia_grandis

   Coccinia grandis, the ivy gourd, also known as scarlet gourd, [2] is a tropical vine. It grows primarily in tropical climates and is commonly found in the Indian states where it forms a part of the local cuisine. Coccinia grandis is cooked as a vegetable dish. In Southeast Asia, it is grown for its edible young shoots and edible fruits. [3]

4. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

   www.aol.com/diabetes-drugs-really-safe-reliable...

   Diabetes Medications as Weight Loss Treatments. Losing weight can be a significant priority for those with overweight and obesity. Carrying excess body weight can lead to medical conditions like ...

5. An experimental drug drove people to lose 23% of their body ...

   www.aol.com/novo-nordisk-next-generation-weight...

   A previous crop of weight-loss drugs, like Qsymia, a combination of older medicines not part of the GLP-1 class, and liraglutide, an earlier GLP-1 medicine sold under the brand name Saxenda ...

6. A diabetes drug may help prevent dementia, new research shows

   www.aol.com/diabetes-drug-may-help-prevent...

   DPP-4 inhibitors are another class of anti-diabetes drugs with a different mechanism. These oral medications work by increasing levels of glucagon-like peptide-1 (GLP-1), which increases insulin ...

7. Lixisenatide - Wikipedia

   en.wikipedia.org/wiki/Lixisenatide

   Sanofi submitted an NDA in the US, which was accepted for review by the US FDA in February 2013, [13] but after discussions with the FDA about the cardiovascular safety data included in the package (starting in 2008, the FDA had required stronger CV safety data for new anti-diabetes drugs, following the controversy around the risks of Avandia ...